WELLTOWER INC. quarterly report, Q3 FY2022

Welltower Inc. — Q3 2022 Form 10-Q

Reporting period: Quarter and nine months ended September 30, 2022. Welltower is a healthcare real estate REIT with Seniors Housing Operating, Triple-net and Outpatient Medical segments across the U.S., U.K. and Canada. Unless indicated otherwise, dollar amounts below are U.S. dollars.

Financial performance and liquidity

MetricQ3 2022Q3 2021Nine months 2022Nine months 2021
Total revenue$1.474 billion$1.240 billion$4.342 billion$3.433 billion
Net income (loss)$(2.7) million$190.3 million$158.8 million$308.3 million
Net income (loss) attributable to common stockholders$(6.8) million; $(0.01) per diluted share$179.7 million; $0.42$144.9 million; $0.32$277.5 million; $0.65
FFO, a non-GAAP measure$362.9 million; $0.78 per diluted share$345.7 million; $0.80$1.120 billion; $2.45$881.7 million; $2.09
Consolidated NOI, a non-GAAP measure$561.7 million$510.4 million$1.722 billion$1.443 billion
Same-store NOI at Welltower’s share, a non-GAAP measure$409.8 million$384.5 million$1.184 billion$1.125 billion

Revenue increased 19% year over year in Q3 and 26% for the nine-month period. Growth reflects portfolio expansion and higher Seniors Housing Operating revenue; it should not be read as same-property growth. Q3 net loss contrasted with prior-year profit, which included $120.0 million of real estate disposition gains. Nine-month net income also declined, in part because prior-year results included larger disposition gains and a debt-extinguishment gain. Nine-month FFO increased 27%, while Q3 FFO per share declined 3% year over year.

Nine-month operating cash flow was $1.075 billion, versus $992.0 million a year earlier. Investing used $3.285 billion, principally for acquisitions, development and other investments; financing provided $2.304 billion. Cash, cash equivalents and restricted cash totaled $425.2 million at period end. Dividends were $0.61 per share for Q3 and $1.83 per share for the nine months, unchanged from comparable 2021 periods.

At September 30, 2022, balance-sheet debt comprised $654.7 million of unsecured credit facility and commercial paper borrowings, $12.325 billion of senior unsecured notes and $2.122 billion of secured debt. Cash and restricted cash were $425.2 million. Management reported approximately $3.8 billion of near-term available liquidity, including $3.345 billion of available revolver capacity. Net debt to book capitalization was 42%; interest coverage was 3.39x for Q3. The company was in material compliance with debt covenants.

Material changes and operating trends

  • Average seniors housing occupancy rose from 74.9% in Q3 2021 to 78.0% in Q3 2022, continuing a quarterly improvement from 76.3% at year-end 2021.
  • Q3 Seniors Housing Operating same-store NOI grew 15.4%; Triple-net grew 2.3%; Outpatient Medical grew 1.3%. The filing attributes overall growth to recovery and portfolio changes, including acquisitions. The 2021 Holiday Retirement acquisition contributed to higher reported Seniors Housing revenue and expenses.
  • The company invested $2.293 billion in acquisitions during the first nine months and issued $2.185 billion net from common stock, primarily through its at-the-market program. It had $2.571 billion of remaining ATM capacity at September 30, excluding outstanding forward-sale agreements.
  • In March, Welltower issued $550 million of 3.85% senior notes due 2032. It amended its unsecured credit facility in June, with $4.0 billion of revolving capacity and term-loan facilities. Commercial paper outstanding was $614.7 million, with a six-day weighted-average maturity and 3.43% weighted-average rate at quarter end.

Outlook, risks and unusual items

  • No specific earnings or FFO guidance is provided in the supplied filing text. Management said liquidity was sufficient for expected uses, subject to availability and cost of external capital.
  • COVID-19, operator and tenant finances, occupancy, labor and health-and-safety costs remain risks. Management expects Seniors Housing Operating expenses to remain elevated during the pandemic and potentially beyond. Nine-month COVID-related property expenses were $28.2 million, partly offset by $33.1 million of government grants recognized as a reduction in operating expenses. Long-term/post-acute operators faced comparatively greater occupancy pressure, which could affect rent payments.
  • Rising rates are a sensitivity: the filing estimates that a 1% increase would raise annual interest expense by $30.5 million on variable-rate debt outstanding at September 30, assuming balances unchanged. Refinancing access and cost, foreign-exchange movements and REIT qualification are also identified risks.
  • Construction in progress was $1.012 billion, with approximately $1.860 billion of additional funding commitments to complete construction. Additional commitments for in-substance real estate investments were $236.5 million.
  • A Q2 2022 agreement resolving litigation with National Health Investors terminated a leasehold interest and generated $58.6 million of other income from derecognizing a right-of-use asset and lease liability; this is a nonrecurring item.
  • In November 2022, Welltower agreed to transition 147 ProMedica skilled nursing facilities and sell them to a new joint venture in which Welltower would own 85% and Integra Health 15%. ProMedica would surrender its 15% interest and receive release from the skilled-nursing lease obligation; working-capital support and regulatory approvals are part of the transition. This post-quarter transaction merits review for terms, execution and operating impacts.
  • Management reported effective disclosure controls. New enterprise resource planning and performance-management systems were implemented during Q3; management said it would continue monitoring related internal controls. No material change to previously disclosed risk factors was reported.

Key facts for investors to verify

  • How much of revenue and NOI growth reflects acquisitions, occupancy recovery and other portfolio changes versus durable same-store performance.
  • Whether occupancy gains continue and whether labor costs, COVID-related expenses and operator liquidity affect operating margins and rent collections.
  • The final terms, regulatory approvals, transition costs and expected financial effects of the ProMedica skilled-nursing transaction.
  • Debt maturity and refinancing plans, variable-rate exposure, liquidity availability and the funding needs for construction and other commitments.
  • Potential dilution and settlement timing from ATM issuances and outstanding forward-sale agreements, alongside the company’s dividend coverage.